$15,000 of CAREDX lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"None"
You can find more data on corporate lobbying on Quiver Quantitative.
CDNA Insider Trading Activity
CDNA insiders have traded $CDNA stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $CDNA stock by insiders over the last 6 months:
- JOHN WALTER JR HANNA (President and CEO) has made 0 purchases and 3 sales selling 29,636 shares for an estimated $626,026.
- JEFFREY ADAM NOVACK (Secretary and General Counsel) has made 0 purchases and 4 sales selling 14,422 shares for an estimated $272,813.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CDNA Hedge Fund Activity
We have seen 94 institutional investors add shares of CDNA stock to their portfolio, and 111 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVESCO LTD. removed 2,433,674 shares (-95.7%) from their portfolio in Q3 2025, for an estimated $35,385,619
- DEERFIELD MANAGEMENT COMPANY, L.P. added 2,191,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $31,857,139
- BRAIDWELL LP added 2,182,781 shares (+inf%) to their portfolio in Q3 2025, for an estimated $31,737,635
- HOOD RIVER CAPITAL MANAGEMENT LLC removed 1,765,981 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $25,677,363
- NEXT CENTURY GROWTH INVESTORS LLC removed 1,125,454 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $16,364,101
- BAMCO INC /NY/ added 719,523 shares (+29.5%) to their portfolio in Q3 2025, for an estimated $10,461,864
- KENT LAKE PR LLC added 550,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $7,996,999
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CDNA Analyst Ratings
Wall Street analysts have issued reports on $CDNA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 11/06/2025
To track analyst ratings and price targets for CDNA, check out Quiver Quantitative's $CDNA forecast page.
CDNA Price Targets
Multiple analysts have issued price targets for $CDNA recently. We have seen 2 analysts offer price targets for $CDNA in the last 6 months, with a median target of $21.5.
Here are some recent targets:
- Brandon Couillard from Wells Fargo set a target price of $18.0 on 12/15/2025
- Mark Massaro from BTIG set a target price of $25.0 on 11/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
